Thermo Fisher partnership with OpenAI aims to accelerate clinical research business

Credit: Gorodenkoff/Shutterstock

Thermo Fisher Scientific plans to improve the speed and success of drug development, enabling customers to get medicines to patients faster and more cost effectively

Register for FREE to keep reading

Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with:

Insights into HPC, AI, lab informatics & data
Curated content for life sciences, engineering & academia
Access to Breakthroughs: real-world computing success
Free reports & panels, including the Lab Informatics Guide
White Papers & software updates for smarter research

Sign up now

Already a member? Log in here

Your data is protected under our privacy policy.

The convergence of HPC and AI: Innovation in the post-Moore’s Law era

At the ISC High Performance 2025 event, hosted in Hamburg, Germany, speakers discussed how innovation in HPC and AI technology is driving advancements that aim to keep pace with Moore's Law, as shrinking transistors become increasingly expensive and challenging to manufacture.